نبذة مختصرة : Context: The initial management of AF is based upon the collaboration between the cardiologist and the general practitioner who plays a major part. Aim: To evaluate management of AF by general practitioners and their relationship to the new diagnosis technologies. Methods: Observational study conducted in Guadeloupe (January – June 2021), based on a mixed method. The first qualitative phase involved a diverse sample of 10 general practitioners diverse in age and workplace, who underwent semi-structured interviews. The second, quantitative involved a random sample of 94 general practitioners (response rate = 39.3%), who were administered an open questionnaire developed from the result of the qualitative phase. Results: 48.9% called on specialists, 35.1% introduced treatments (mostly oral anticoagulants directs, after non protocolized evaluation of cardiovascular risk), 18.1% sent to emergency. 56.4% knew about the new diagnosis technologies, 64.9% recognized a screening benefit, despite anxiety-risks (57.5%). The treatment initiation was mainly associated to the perceived role of screening and diagnosis done by the general practitioner in AF’s management. Conclusion: Most of the general practitioner in Guadeloupe taking in charge AD did so by following recommendations. The contribution of new diagnosis technologies could help to manage better the pathology in the future. ; Contexte : La prise en charge initiale de la FA repose sur la collaboration entre le cardiologue et médecin généraliste qui joue un rôle majeur. Objectif : Évaluer la prise en charge de la FA par les médecins généralistes ambulatoires, ainsi que leur rapport aux nouvelles technologies diagnostiques. Méthodes : Etude observationnelle, menée en Guadeloupe (janvier – juin 2021), selon une méthode mixte. La première phase, qualitative, portait sur 10 médecins diversifiés en âge et lieu d'exercice, vus en entretiens semi-dirigés. La seconde, quantitative a porté sur un échantillon aléatoire composé de 94 médecins généralistes (taux de réponse = ...
No Comments.